Skip to content

Comparison of the Block Characteristics of USG Guided Costoclavicular and Infraclavicular Block With the Perfusion Index

Comparison of the Block Characteristics of Ultrasound Guided Costoclavicular and Infraclavicular Block With the Perfusion Index

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT04857216
Enrollment
90
Registered
2021-04-23
Start date
2021-03-14
Completion date
2021-07-30
Last updated
2021-09-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Costoclavicular and Infraclavicular Block for Patients Who Have Undergone Hand,Forearm and Arm Surgery

Keywords

infraclavicular, costoclavicular, perfusion index, block

Brief summary

With this study, it was aimed to compare the block characteristics evaluated with traditional methods in infraclavicular and costoclavicular block applications performed in upper extremity surgery in our clinic with the perfusion index

Detailed description

Peripheral nerve block is to anesthetize the dermatomes belonging to the nerve or nerve group to which the block is applied, by performing sympathetic, sensory and motor blocks. Brachial plexus blockade; It is a peripheral nerve blockage that can be used in surgical operations to be performed on the upper extremity and can be performed at the level of interscalene, supraclavicular, infraclavicular, costoclavicular, axillary and terminal nerves. The costoclavicular brachial plexus block has been used as an alternative to lateral sagittal infraclavicular block, due to its ease of application, its rapid onset of action and its high success rate. The effectiveness of the block is measured by sensory, motor and sympathetic block effects. The sensory block can be evaluated by cold or pinprick test, and motor block by traditional methods such as the patient's response to verbal commands and can be objective. Sympathetic block manifests itself with vasodilation and an increase in blood flow rate and can be measured with the more quantitative perfusion index (PI). The perfusion index represents the ratio of pulsatile blood flow to static blood flow in peripheral tissue and can be measured continuously and noninvasively from a pulse oximeter. Successful peripheral nerve blockade; It is seen as local vasodilation, increased local blood flow, some increase in skin temperature and loss of sensation in the extremity due to the blockage of sympathetic fibers. It can be a guide in determining the effectiveness of the block because it is noninvasive and easy, providing rapid evaluation, without requiring patient cooperation to evaluate the success of the block.

Interventions

DEVICEPerfusion Index

perfusion index in the prediction of peripheral block success was previously reported for infraclavicular brachial plexus block, axillary brachial plexus block, interscalene brachial plexus block, and supraclavicular brachial plexus in adult patients

Sponsors

Izmir Ataturk Training and Research Hospital
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum

Inclusion criteria

* All costoclavicular and infraclavicular block patients who have undergone hand,forearm and arm surgery * Patients over the age of 18

Exclusion criteria

* Patients who do not want to participate in the study * Patients whose peripheral block administration is contraindicated

Design outcomes

Primary

MeasureTime frameDescription
Correlation of perfusion index with infraclavicular and costoclavicular block success3 MonthsCorrelation of perfusion index with infraclavicular and costoclavicular block success

Secondary

MeasureTime frameDescription
Comparison of the Block Characteristics of Ultrasound Guided Costoclavicular and Infraclavicular Block3 MonthsComparison of the Block Characteristics of Ultrasound Guided Costoclavicular and Infraclavicular Block

Countries

Turkey (Türkiye)

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026